Results 131 to 140 of about 1,042 (177)

Prurigo nodularis [PDF]

, 2020
Arvesen, Kristian Bakke, Bjerring, Peter, Mikkelsen, Carsten Sauer, Penninga, Luit, Ternowitz, Thomas   +4 more
core  

Efficacy and Safety of Nemolizumab in Patients With Prurigo Nodularis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]

Cureus
Sinha K, Sinha T, Muppa N, Kanwal N, Blair K, Chaudhari SS, Wei CR, Amin A.   +7 more
europepmc   +1 more source

Severe Atopic Dermatitis With Increasing Daytime Sleepiness Following Nemolizumab Administration: A Case Report. [PDF]

Cureus
Horimukai K, Kinoshita M, Takahata N.
europepmc   +1 more source

Nemolizumab Treatment Normalizes Dysregulated Microbiome in Lesional Prurigo Nodularis

Journal of Investigative Dermatology
Ruiwen Zhou, Prasad Chaskar, Matthew T. Patrick, Kai Wang, Christophe Piketty, Valerie Julia, Johann E. Gudjonsson, Jayendra Kumar Krishnaswamy, Lam C. Tsoi   +8 more
openaire   +1 more source

Advancing Therapeutic Strategies in Atopic Dermatitis: Emerging Targets and Personalized Approaches. [PDF]

Biomolecules
Lo Y, Cheng TT, Huang CJ, Cheng YC, Chyuan IT.   +4 more
europepmc   +1 more source

Rocatinlimab: A Novel T-Cell Rebalancing Therapy Targeting the OX40 Receptor in Atopic Dermatitis. [PDF]

Dermatol Ther (Heidelb)
Guttman-Yassky E, Simpson E, Esfandiari E, Mano H, Bauer J, Charuworn P, Kabashima K.   +6 more
europepmc   +1 more source

Monoclonal Antibodies (mAbs) and Proteins: The Biologic Drugs Approved by the Food and Drug Administration (FDA) in 2024. [PDF]

Biomedicines
Martins AC, Oshiro MY, Schiavon BN, de Jesus GA, de la Torre BG, Albericio F.   +5 more
europepmc   +1 more source

Successful Treatment of Pediatric Atopic Prurigo Nodularis with Dupilumab. [PDF]

Clin Cosmet Investig Dermatol
Zhang Y, Liang L, Li C.
europepmc   +1 more source